Actively Recruiting
the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
Led by Kafrelsheikh University · Updated on 2024-10-29
716
Participants Needed
1
Research Sites
122 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.
CONDITIONS
Official Title
the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals of both genders aged 18 to 75 years
- Acute first-ever embolic ischemic stroke
- Diagnosis of atrial fibrillation
- Eligible for thrombolysis treatment with alteplase
You will not qualify if you...
- Contraindications for alteplase treatment
- Did not receive the full dose of alteplase
- History of persistent or recurrent CNS disorders such as epilepsy, meningioma, or multiple sclerosis
- Recurrent ischemic stroke diagnosed by clinical history or MRI
- Symptoms of major organ failure, active cancer, or recent acute myocardial infarction within six weeks
- Pregnant or lactating patients
- Stroke due to venous thrombosis or following cardiac arrest
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kafr Elsheikh University Hospital
Kafr ash Shaykh, Egypt, 33511
Actively Recruiting
Research Team
M
mohamed G. Zeinhom, MD
CONTACT
S
sherihan R. ahmed, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here